The IPO Buzz: Apnimed (APMD Proposed) Launches $150 Million IPO
Apnimed (APMD Proposed), a Phase 3 biotech developing what could become the first FDA-approved pill to treat obstructive sleep apnea, disclosed its IPO’s terms and launched the $150 million deal early today – Monday, July 27, 2026. Apnimed is offering 10 million shares at a price range of $14.00 to $16.00 to raise $150 million, if priced at the $15.00 mid-point of its range. The market cap would be $569.85 million.
BofA Securities, Evercore ISI, Cantor and LifeSci Capital are the joint book-runners.
Bankers expect to price Apnimed’s IPO on Thursday night, July 30, to trade Friday, July 31,on the NASDAQ.
Apnimed, based in Cambridge, Massachusetts, has only one clinical drug candidate – AD109 – also known as Oxnimbi, a pill in a fixed-dose formula to treat obstructive sleep apnea. The biotech has evaluated Oxnimbi in 1,300 patients so far in several Phase 3 trials, the prospectus said.
“AD109 is a combination of a novel anti-muscarinic and a selective norepinephrine reuptake inhibitor.,” the prospectus said. “This drug candidate is designed to improve upper airway muscle activity to prevent airway collapse during sleep.”
Apnimed plans to spend about $228 million – including $134 million anticipated as the IPO’s net proceeds – to fund the regulatory approval process and the commercial launch of Oxnimbi, the prospectus said.
Apnimed’s principal stockholders include Japan’s Shionogi, which in the early 1990s discovered rosuvastatin, the active ingredient in Crestor, a blockbuster drug to lower cholesterol levels.
(For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on the IPOScoop.com website.)
Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.
To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.
Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.
Source: https://www.iposcoop.com/the-ipo-buzz-apnimed-apmd-proposed-launches-150-million-ipo/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
| Visits: | 1,825,574,955 |
| Stories: | 8,676,953 |
Whistler Blowers, Insiders
